跳至主要内容
临床试验/NCT02918110
NCT02918110Unknown4 期

Vaginal Misodel® in Comparison With Orally Administrated Misoprostol (Cytotec®) at Induction of Labour

Karolinska Institutet1 个研究点 分布在 1 个国家目标入组 320 人开始时间: 2016年9月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
320
试验地点
1
主要终点
Cesarean section rate

研究概览

简要总结

The study will compare orally administrated solution of Misoprostol (Cytotec®) with vaginal slow release (7ug/h) Misoprostol (Misodel®) regarding efficacy and safety during labour.

详细描述

To compare orally administrated solution of misoprostol (Cytotec®) with vaginal slow release misoprostol (Misodel®) regarding efficacy and safety during labour Design: Randomised controlled trial (RCT)

Settings:

Obstetric departments of Sodersjukhuset, Stockholm Obstetric departments of Women's clinic, Karlstad.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Primipara BS ≤ 4p Gestational week >37

排除标准

  • Multipara Multiples Gestational week <37 BS >4 IUFD Previous uterine surgery

研究组 & 干预措施

Cytotec

Experimental

orally administrated solution of misoprostol (Cytotec®)

干预措施: Misoprostol (Drug)

Misodel

Experimental

vaginal slow release misoprostol (Misodel®)

干预措施: Misoprostol (Drug)

结局指标

主要结局

Cesarean section rate

时间窗: 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eva Wiberg-Itzel

Associate Professor

Karolinska Institutet

研究点 (1)

Loading locations...

相似试验